Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C16H18N2Na2O14S2
CAS Number:
Molecular Weight:
572.43
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352106
MDL number:
Assay:
≥95% (H-NMR)
Form:
powder
Solubility:
H2O: 10 mg/mL, soluble
InChI key
MGJYOHMBGJPESL-UHFFFAOYSA-L
SMILES string
[Na+].[Na+].[O-]S(=O)(=O)C1CC(=O)N(OC(=O)CCCCCCC(=O)ON2C(=O)CC(C2=O)S([O-])(=O)=O)C1=O
InChI
1S/C16H20N2O14S2.2Na/c19-11-7-9(33(25,26)27)15(23)17(11)31-13(21)5-3-1-2-4-6-14(22)32-18-12(20)8-10(16(18)24)34(28,29)30;;/h9-10H,1-8H2,(H,25,26,27)(H,28,29,30);;/q;2*+1/p-2
assay
≥95% (H-NMR)
form
powder
reaction suitability
reagent type: cross-linking reagent
solubility
H2O: 10 mg/mL, soluble
storage temp.
−20°C
Quality Level
Related Categories
Application
Suberic acid bis(3-sulfo-N-hydroxysuccinimide ester) sodium salt (BS3) is useful for the preparation of protein-protein, receptor-ligand and hapten carrier molecule conjugates.
General description
Suberic acid bis(3-sulfo-N-hydroxysuccinimide ester) sodium salt (BS3) is a water soluble, homobifunctional cross-linking reagent with amine reactivity. It is typically coupled to molecules containing primary amines by amide bonds buffered at pH 7.5 (6.5-8.5). It incorporates 8-atom linker.
Storage Class
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Modelling the structure of latexin-carboxypeptidase A complex based on chemical cross-linking and molecular docking.
Mouradov D
Protein engineering, design & selection : PEDS, 19, 9-16 (2006)
Modified apolipoprotein (apo) A-I by artificial sweetener causes severe premature cellular senescence and atherosclerosis with impairment of functional and structural properties of apoA-I in lipid-free and lipid-bound state.
Jang W
Molecular Cell, 31, 461-461 (2011)
Maarten van Dinther et al.
PloS one, 8(4), e62295-e62295 (2013-05-03)
Sclerosteosis is a rare high bone mass disease that is caused by inactivating mutations in the SOST gene. Its gene product, Sclerostin, is a key negative regulator of bone formation and might therefore serve as a target for the anabolic
Huawen Lin et al.
PLoS genetics, 9(9), e1003841-e1003841 (2013-10-03)
Whole genome sequencing is a powerful tool in the discovery of single nucleotide polymorphisms (SNPs) and small insertions/deletions (indels) among mutant strains, which simplifies forward genetics approaches. However, identification of the causative mutation among a large number of non-causative SNPs
Hermanson GT
Bioconjugate Techniques (2013)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service